FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Tadalafil Tablets Recall

Tadalafil Tablets, USP 5 mg, 30 count bottle, Rx Only, Manufactured for: Northstar Rx L…

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class II
Reported by FDA
Nov 17, 2021
Recall ID
D-0230-2022
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Tadalafil Tablets starting Oct 25, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0230-2022 on Nov 17, 2021. Reason: Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product. Status: Terminated.

Why it was recalled

Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.

Product description

Tadalafil Tablets, USP 5 mg, 30 count bottle, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Industries Limited, India, NDC # 16714-075-01

Lot numbers, UPCs & expiration codes

Lot # DNC1127A, exp. date 05/2023

Where it was sold

Distributed to one distributor who may have further distribute the product nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0230-2022
Classification
Class II
Status
Terminated
Recall initiated
Oct 25, 2021
FDA report date
Nov 17, 2021
Quantity
73,957 30-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0230-2022, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
88873
Address
2 Independence Way
Code information
Lot # DNC1127A, exp. date 05/2023
Postal code
08540-6620
Report date
Nov 17, 2021
Product type
Drugs
Recall number
D-0230-2022
Classification
Class II
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
73,957 30-count bottles
Termination date
Sep 1, 2022
Reason for recall
Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tadalafil Tablets, USP 5 mg, 30 count bottle, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Industries Limited, India, NDC # 16714-075-01
Distribution pattern
Distributed to one distributor who may have further distribute the product nationwide.
Recall initiation date
Oct 25, 2021
Initial firm notification
Letter
Center classification date
Nov 12, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0230-2022, published Nov 17, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls